Immunosuppressant Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020

Immunosuppressant Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, “Immunosuppressant Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020 provides comprehensive information about the Immunosuppressant Therapeutic Drug Monitoring Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunosuppressant Therapeutic Drug Monitoring are the reagents used for the detection of immunosuppressant concentration in human body are covered under immunosuppressant TDM surgical devices that are used to make a tiny incision in the areas to be operated.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunosuppressant Therapeutic Drug Monitoring Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunosuppressant Therapeutic Drug Monitoring Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunosuppressant Therapeutic Drug Monitoring Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Immunosuppressant Therapeutic Drug Monitoring Tests Overview
  • Products under Development
    • Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
      • Table Figure 1: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
      • Table Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
    • Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory
      • Table Figure 2: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory
      • Table Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory
    • Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
      • Table Figure 3: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
      • Table Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
    • Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
      • Table Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
  • Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products under Development by Companies
    • Immunosuppressant Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
      • Table Immunosuppressant Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
    • Immunosuppressant Therapeutic Drug Monitoring – Companies Pipeline Products by Stage of Development
      • Table Immunosuppressant Therapeutic Drug Monitoring – Companies Pipeline Products by Stage of Development
  • Immunosuppressant Therapeutic Drug Monitoring Companies and Product Overview
    • BIOHOPE Scientific SL Company Overview
      • BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Immunobiogram - Renal Transplantation - Product Status
        • Table Immunobiogram - Renal Transplantation - Product Description
    • Laboratory Corp of America Holdings Company Overview
      • Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview
        • Table Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview
        • Table DoseASSURE RTX Assay - Product Status
        • Table DoseASSURE RTX Assay - Product Description
    • Ortho-Clinical Diagnostics Inc Company Overview
      • Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VITROS XT 7600 Integrated System - Cedia Cyclosporine Assay - Product Status
        • Table VITROS XT 7600 Integrated System - Cedia Cyclosporine Assay - Product Description
        • Table VITROS XT 7600 Integrated System - Cedia Mycophenolic Acid Assay - Product Status
        • Table VITROS XT 7600 Integrated System - Cedia Mycophenolic Acid Assay - Product Description
        • Table VITROS XT 7600 Integrated System - Methotrexate Assay - Product Status
        • Table VITROS XT 7600 Integrated System - Methotrexate Assay - Product Description
        • Table VITROS XT 7600 Integrated System - QMS Everolimus Assay - Product Status
        • Table VITROS XT 7600 Integrated System - QMS Everolimus Assay - Product Description
        • Table VITROS XT 7600 Integrated System - QMS Tacrolimus Assay - Product Status
        • Table VITROS XT 7600 Integrated System - QMS Tacrolimus Assay - Product Description
    • Progenika Biopharma SA Company Overview
      • Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Promonitor - Autoimmune And Inflammation - Product Status
        • Table Promonitor - Autoimmune And Inflammation - Product Description
    • Roche Diagnostics International Ltd Company Overview
      • Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cobas - Cyclosporin A Assay - Product Status
        • Table Cobas - Cyclosporin A Assay - Product Description
        • Table Cobas 4000 Analyzer Series With e 411 Module - Cyclosporine Assay - Product Status
        • Table Cobas 4000 Analyzer Series With e 411 Module - Cyclosporine Assay - Product Description
        • Table Cobas 4000 Analyzer Series With e 411 Module - Tacrolimus Assay - Product Status
        • Table Cobas 4000 Analyzer Series With e 411 Module - Tacrolimus Assay - Product Description
        • Table Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Status
        • Table Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Description
        • Table Cobas 6000 Analyzer Series With c 501 Module - Everolimus Assay - Product Status
        • Table Cobas 6000 Analyzer Series With c 501 Module - Everolimus Assay - Product Description
        • Table Cobas 6000 Analyzer Series With c 501 Module - Sirolimus Assay - Product Status
        • Table Cobas 6000 Analyzer Series With c 501 Module - Sirolimus Assay - Product Description
        • Table Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Status
        • Table Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Description
        • Table Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Status
        • Table Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Description
        • Table Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Status
        • Table Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Description
        • Table Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Status
        • Table Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 502 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 502 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 502 Module - Sirolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 502 Module - Sirolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 502 Module - Tacrolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 502 Module - Tacrolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 701 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 701 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 701 Module - Sirolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 701 Module - Sirolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 701 Module - Tacrolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 701 Module - Tacrolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 702 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 702 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 702 Module - Sirolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 702 Module - Sirolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With c 702 Module - Tacrolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With c 702 Module - Tacrolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 602 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 602 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 801 Module - Everolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 801 Module - Everolimus Assay - Product Description
        • Table Cobas 8000 Analyzer Series With e 801 Module - Tacrolimus Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 801 Module - Tacrolimus Assay - Product Description
        • Table Integrated Modular Analytics - Tacrolimus Test - Product Status
        • Table Integrated Modular Analytics - Tacrolimus Test - Product Description
        • Table Integrated Modular Analytics System - Mycophenolic Acid Test - Product Status
        • Table Integrated Modular Analytics System - Mycophenolic Acid Test - Product Description
    • Siemens Healthcare Diagnostics Inc Company Overview
      • Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ADVIA Centaur CP Immunoassay System - Everolimus Assay - Product Status
        • Table ADVIA Centaur CP Immunoassay System - Everolimus Assay - Product Description
        • Table ADVIA Centaur CP Immunoassay System - Sirolimus Assay - Product Status
        • Table ADVIA Centaur CP Immunoassay System - Sirolimus Assay - Product Description
        • Table ADVIA Centaur CP Immunoassay System - Tacrolimus Assay - Product Status
        • Table ADVIA Centaur CP Immunoassay System - Tacrolimus Assay - Product Description
        • Table ADVIA Centaur XP Immunoassay System - Everolimus Assay - Product Status
        • Table ADVIA Centaur XP Immunoassay System - Everolimus Assay - Product Description
        • Table ADVIA Centaur XP Immunoassay System - Sirolimus Assay - Product Status
        • Table ADVIA Centaur XP Immunoassay System - Sirolimus Assay - Product Description
        • Table ADVIA Centaur XP Immunoassay System - Tacrolimus Assay - Product Status
        • Table ADVIA Centaur XP Immunoassay System - Tacrolimus Assay - Product Description
        • Table ADVIA Centaur XPT Immunoassay System - Everolimus Assay - Product Status
        • Table ADVIA Centaur XPT Immunoassay System - Everolimus Assay - Product Description
        • Table ADVIA Centaur XPT Immunoassay System - Sirolimus Assay - Product Status
        • Table ADVIA Centaur XPT Immunoassay System - Sirolimus Assay - Product Description
        • Table ADVIA Centaur XPT Immunoassay System - Tacrolimus Assay - Product Status
        • Table ADVIA Centaur XPT Immunoassay System - Tacrolimus Assay - Product Description
        • Table Atellica IM Analyzer - Everolimus Assay - Product Status
        • Table Atellica IM Analyzer - Everolimus Assay - Product Description
        • Table Atellica IM Analyzer - Sirolimus Assay - Product Status
        • Table Atellica IM Analyzer - Sirolimus Assay - Product Description
        • Table Dimension EXL 200 Integrated Chemistry System - Everolimus Assay - Product Status
        • Table Dimension EXL 200 Integrated Chemistry System - Everolimus Assay - Product Description
    • Thermo Fisher Scientific Inc Company Overview
      • Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cascadion SM Immunosuppressants Panel - Product Status
        • Table Cascadion SM Immunosuppressants Panel - Product Description
  • Immunosuppressant Therapeutic Drug Monitoring- Recent Developments
    • Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop nextgeneration sequencing-based diagnostics in Russia
    • Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fasttrack construction of smart biotech facilities
    • May 14, 2020: Aurinia reports first quarter 2020 financial results and recent operational highlights
    • Mar 09, 2020: THERADIAG announces the CE Marking for the first four i-Tracker Test Kits in its TRACKER Range
    • Mar 05, 2020: Aurinia reports fourth quarter and full year 2019 financial results and operational highlights
    • Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors
    • Feb 25, 2020: Aurinia appoints Max Colao as Chief Commercial Officer and expands U.S. commercial leadership team
    • Feb 04, 2020: Waters reports fourth quarter and full-year 2019 financial results
    • Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
    • Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results
    • Jan 30, 2020: Theradiag reports 2019 revenue of €9.6 million, Up 8.3%
    • Jan 02, 2020: Agilent expands cross-vendor CDS instrument control
    • Dec 11, 2019: Biohope receives ISO certification for the commercialization of IMBG test
    • Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings